Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Mashup Score: 1


The answer here is NO. Having another option that provides no evidence of superiority but adds a year of treatment,… https://t.co/37Y0BugbHd

  • 123456 Profile photo of Madelyn

    Dr. Jack West of City of Hope gives his take on the presented results of the AGEAN trial looking at neoadjuvant chemo + IO followed by adjuvant IO in NSCLC. More IO may not be the answer but survival data not mature.